TrialInternational journal of clinical oncology2020

Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.

Koji Ando et al.PubMed ↗Publisher ↗

No numbers read from the abstract.